Publication:
Prognostic risk factors in ventilator-associated pneumonia

dc.contributor.buuauthorKarakuzu, Ziyaettin
dc.contributor.buuauthorİşçimen, Remzi
dc.contributor.buuauthorAkalın, Halis
dc.contributor.buuauthorGirgin, Nermin Kelebek
dc.contributor.buuauthorKahveci, Ferda
dc.contributor.buuauthorSınırtaş, Melda
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentMikrobiyoloji ve Enfeksiyon Hastalıkları Ana Bilim Dalı
dc.contributor.orcid0000-0001-8111-5958tr_TR
dc.contributor.researcheridFAL-0396-2022
dc.contributor.researcheridHKP-2533-2023
dc.contributor.researcheridAAU-8952-2020
dc.contributor.researcheridAAH-7250-2019
dc.contributor.researcheridCYR-2043-2022
dc.contributor.researcheridDSE-4824-2022
dc.contributor.scopusid56088206300tr_TR
dc.contributor.scopusid16645821200tr_TR
dc.contributor.scopusid57207553671tr_TR
dc.contributor.scopusid55663009300tr_TR
dc.contributor.scopusid6602405968tr_TR
dc.contributor.scopusid6505818048tr_TR
dc.date.accessioned2024-03-27T07:21:25Z
dc.date.available2024-03-27T07:21:25Z
dc.date.issued2018-03-05
dc.description.abstractBackground: Ventilator-associated pneumonia (VAP) is a nosocomial infection commonly seen in patients in intensive care units (ICU). This study aimed to analyze factors affecting prognosis of patients diagnosed with VAP. Material/Methods: Critically ill patients with VAP were retrospectively evaluated between June 2002 and June 2011 in the ICU. VAP diagnosis was made according to 2005 ATS/IDSA (Infectious Diseases Society of America/American Thoracic Society) criteria. First pneumonia attacks of patients were analyzed. Results: When early-and late-onset pneumonia causes were compared according to ICU and hospital admittance, resistant bacteria were found to be more common in pneumonias classified as early-onset according to ICU admittance. APACHE II score of >21 (p=0.016), SOFA score of >6 (p<0.001) on admission to ICU and SOFA score of >6 (p<0.001) on day of diagnosis are risk factors affecting mortality. Additionally, low PaO2/FIO2 ratio at onset of VAP had a negative effect on prognosis (p<0.001). SOFA score of >6 on the day of VAP diagnosis was an independent risk factor for mortality [(p<0.001; OR (95% CI): 1.4 (1.2-1.6)]. Conclusions: Resistant bacteria might be present in early-onset VAP. Especially, taking LOS into consideration may better estimate the presence of resistant bacteria. Acinetobacter baumannii, Pseudomonas aeruginosa, and methicillin-resistant Staphylococcus aureus (MRSA) were the most frequent causative microorganisms for VAP. SOFA score might be more valuable than APACHE II score. Frequently surveilling SOFA scores may improve predictive performance over time.en_US
dc.identifier.citationKarakuzu, Z. vd. (2018). ''Prognostic risk factors in ventilator-associated pneumonia''. Medical Science Monitor, 24, 1321-1328.en_US
dc.identifier.doihttps://doi.org/10.12659/MSM.905919
dc.identifier.endpage1328tr_TR
dc.identifier.issn1643-3750
dc.identifier.pubmed29503436tr_TR
dc.identifier.scopus2-s2.0-85042930166tr_TR
dc.identifier.startpage1321tr_TR
dc.identifier.urihttps://medscimonit.com/abstract/index/idArt/905919
dc.identifier.urihttps://hdl.handle.net/11452/40633
dc.identifier.volume24tr_TR
dc.identifier.wos000427517100001
dc.indexed.pubmedPubMeden_US
dc.indexed.scopusScopusen_US
dc.indexed.wosSCIEen_US
dc.language.isoenen_US
dc.publisherInternational Scientific Informationen_US
dc.relation.journalMedical Science Monitoren_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectResearch & experimental medicineen_US
dc.subjectMortalityen_US
dc.subjectOrgan dysfunction scoresen_US
dc.subjectPneumonia, ventilator-associateden_US
dc.subjectRisk factorsen_US
dc.subjectIntensive-care-uniten_US
dc.subjectContinuous mechanical ventilationen_US
dc.subjectCritical-ill patientsen_US
dc.subjectTracheal colonizationen_US
dc.subjectAntibiotic-therapyen_US
dc.subjectSeptic shocken_US
dc.subjectApache-llen_US
dc.subjectMortalityen_US
dc.subjectInfectionsen_US
dc.subjectInitiationen_US
dc.subject.emtreeCorticosteroiden_US
dc.subject.emtreeAcinetobacter baumanniien_US
dc.subject.emtreeAdulten_US
dc.subject.emtreeAPACHEen_US
dc.subject.emtreeArticleen_US
dc.subject.emtreeArtificial ventilationen_US
dc.subject.emtreeBacteremiaen_US
dc.subject.emtreeDialysisen_US
dc.subject.emtreeFemaleen_US
dc.subject.emtreeGlasgow coma scaleen_US
dc.subject.emtreeHospital admissionen_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeKlebsiella pneumoniaeen_US
dc.subject.emtreeLength of stayen_US
dc.subject.emtreeMajor clinical studyen_US
dc.subject.emtreeMaleen_US
dc.subject.emtreeMiddle ageden_US
dc.subject.emtreeMortalityen_US
dc.subject.emtreeOxygen tensionen_US
dc.subject.emtreePositive end expiratory pressureen_US
dc.subject.emtreePrognosisen_US
dc.subject.emtreePseudomonas aeruginosaen_US
dc.subject.emtreeReceiver operating characteristicen_US
dc.subject.emtreeRetrospective studyen_US
dc.subject.emtreeRisk factoren_US
dc.subject.emtreeSequential organ failure assessment scoreen_US
dc.subject.emtreeTidal volumeen_US
dc.subject.emtreeVentilator associated pneumoniaen_US
dc.subject.emtreeAntibiotic resistanceen_US
dc.subject.emtreeCross infectionen_US
dc.subject.emtreeIntensive care uniten_US
dc.subject.emtreeMethicillin resistant Staphylococcus aureusen_US
dc.subject.emtreePathogenicityen_US
dc.subject.emtreePathophysiologyen_US
dc.subject.emtreePneumoniaen_US
dc.subject.emtreePrognosisen_US
dc.subject.emtreeRisk factoren_US
dc.subject.emtreeVentilator associated pneumoniaen_US
dc.subject.meshAcinetobacter baumanniien_US
dc.subject.meshCross infectionen_US
dc.subject.meshDrug resistance, bacterialen_US
dc.subject.meshFemaleen_US
dc.subject.meshHumansen_US
dc.subject.meshIntensive care unitsen_US
dc.subject.meshMaleen_US
dc.subject.meshMethicillin-resistant staphylococcus aureusen_US
dc.subject.meshMiddle ageden_US
dc.subject.meshPneumoniaen_US
dc.subject.meshPneumonia, ventilator-associateden_US
dc.subject.meshPrognosisen_US
dc.subject.meshPseudomonas aeruginosaen_US
dc.subject.meshRespiration, artificialen_US
dc.subject.meshRetrospective studiesen_US
dc.subject.meshRisk factorsen_US
dc.subject.scopusVentilator Associated Pneumonia; Anti-Bacterial Agents; Piperacillin Plus Tazobactamen_US
dc.subject.wosMedicine, research & experimentalen_US
dc.titlePrognostic risk factors in ventilator-associated pneumoniaen_US
dc.typeArticleen_US
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Anesteziyoloji ve Reanimasyon Ana Bilim Dalıtr_TR
local.contributor.departmentTıp Fakültesi/Mikrobiyoloji ve Enfeksiyon Hastalıkları Ana Bilim Dalıtr_TR

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: